Crispina Calsada Regulus Therapeutics Inc. (RGLS) insider trading activity
Crispina Calsada is Chief Financial Officer of Regulus Therapeutics Inc.. Currently has a direct ownership of 5,782 shares of RGLS, which is worth approximately $8,615. The most recent transaction as insider was on Jan 18, 2024, when has been sold 5,468 shares (Common Stock) at a price of $1.19 per share, resulting in proceeds of $6,506. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
5.78K
0%
3M change
n/a
12M change
Total Value Held
$8,615
CC
Crispina Calsada
Chief Financial Officer
San Diego, CA